Related Experiment Video

Updated: May 13, 2026

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay
09:03

Parallel Interrogation of β-Arrestin2 Recruitment for Ligand Screening on a GPCR-Wide Scale using PRESTO-Tango Assay

Published on: March 10, 2020

Structural basis of PTH1R-β-arrestin core engagement reveals design principles for G-protein-biased therapeutics

Li-Hua Zhao1, Qian He2,3, Qingning Yuan4

  • 1Research Center for Medicinal Structural Biology, National Research Center for Translational Medicine at Shanghai, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. zlh13131@rjh.com.cn.

Nature Structural & Molecular Biology
|May 11, 2026
PubMed

Insights

Researchers revealed the structure of a key receptor (parathyroid hormone receptor 1) interacting with β-arrestin 1. This finding enables the design of biased signaling drugs targeting G-protein-coupled receptors (GPCRs) for therapeutic benefits.

Area of Science:

  • Structural Biology
  • Pharmacology
  • Molecular Cell Biology

Background:

  • G-protein-coupled receptors (GPCRs) mediate cellular signals via G protein and arrestin pathways.
  • Biased signaling, selectively activating specific pathways, offers therapeutic potential.
  • Structural insights into class B GPCR-arrestin interactions are limited.

Purpose of the Study:

  • To determine the cryo-electron microscopy structure of parathyroid hormone receptor 1 (PTH1R) in complex with β-arrestin 1.
  • To elucidate the molecular mechanisms underlying arrestin coupling to class B GPCRs.
  • To design and validate biased agonists for class B GPCRs.

Main Methods:

  • Cryo-electron microscopy (cryo-EM) to determine the structure of PTH1R-β-arrestin 1 complex.
  • Conformational analysis of transmembrane helix 5 (TM5) and extracellular loop 3 (ECL3).
  • Design and synthesis of peptide analogs targeting specific conformational changes.
  • In vivo efficacy testing in an ovariectomized mouse model.

Main Results:

  • The structure reveals a unique rearrangement of TM5 and ECL3 crucial for β-arrestin 1 binding.
  • Peptide analogs designed to inhibit these conformational changes act as G-protein-biased agonists.
  • These biased agonists maintain efficacy while reducing arrestin recruitment.
  • A lead compound demonstrated therapeutic efficacy in a mouse model.

Conclusions:

  • The study provides the first structural basis for arrestin coupling to a class B GPCR.
  • Structure-guided design of biased agonists targeting class B GPCRs is feasible.
  • This work offers a framework for developing novel therapeutics with improved selectivity and reduced side effects.

More Related Videos

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery08:21

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery

Published on: June 28, 2019

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding10:13

Measuring G-protein-coupled Receptor Signaling via Radio-labeled GTP Binding

Published on: June 9, 2017

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...